YOLFTbeta
Multi Medika Internasional

Multi Medika Internasional

MMIX · JK · Healthcare / Pharmaceutical Retailers

408.00IDR-30.00 (-6.85%)

Price History

Full chart

Market Stats

Previous Close438.00
Open408.00
Day Range408.00 – 438.00
52-Week Range166.00 – 940.00
Volume49.50M
Market Cap4.44T
P/E (TTM)23.96
Forward P/E0.00
EPS38.61
Dividend Yield0.00%
Beta1.57
50-Day Avg798.40
200-Day Avg468.42

About

PT Multi Medika Internasional Tbk engages in the wholesale of laboratory, pharmaceutical, and medical equipment in Indonesia. It is involved in the property leasing; wholesale of agricultural food and beverages, livestock and fishery food and beverages, non-alcoholic and non-diary beverages, textile goods, cosmetics, and other household goods and equipment; management consulting; courier agency activities; web portals; travel, conferences, and exhibitions; and meeting and event organizer services. The company was founded in 2020 and is based in Jakarta Barat, Indonesia. PT Multi Medika Internasional Tbk operates as a subsidiary of PT Multi Inti Usaha.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Mengky Mangarek M.B.A., S.E.
  • Employees145
  • HeadquartersJl. Peternakan III No.55B, Jakarta Barat, Indonesia, 11720, Indonesia
  • Websitehttps://www.multimed.co.id

Leadership

  • Mr. Mengky Mangarek M.B.A., S.E.Founder & President Director · b. 1972
  • Ms. Eveline Natalia SusantoCo-Founder, CFO, Director of Finance & Accounting and Director · b. 1972
  • Ms. Stia NoermayanthyCorporate Secretary · b. 1988

Financials

Income Statement

Currency: IDR2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.48B181.84B175.09B175.13B191.99B201.47B
Growth (%)-+12163.33%-3.71%+0.02%+9.62%+4.94%
Cost of Revenue1.00B114.15B83.78B70.26B80.58B81.04B
Gross Profit481.40M67.70B91.31B104.87B111.41B120.43B
Gross Margin32.47%37.23%52.15%59.88%58.03%59.77%
Operating Expense119.45M31.31B59.29B76.31B87.41B84.24B
Operating Income361.95M36.39B32.03B28.56B24.00B36.19B
Operating Margin24.41%20.01%18.29%16.31%12.50%17.96%
EBITDA-33.58B----
EBITDA Margin-18.47%----
Net Income352.88M25.04B23.67B16.51B1.21B5.24B
Net Income Margin23.80%13.77%13.52%9.43%0.63%2.60%
Interest Expense-880.21M-130.79M790.76M231.47M
Interest Expense % of Total Revenue-0.48%-0.07%0.41%0.11%

Balance Sheet

Currency: IDR2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.25B109.27B196.87B325.45B407.82B418.86B
Total Liabilities1.90B82.87B33.87B145.97B227.24B232.71B
Total Equity1.35B26.40B163.00B179.48B180.58B186.14B
Cash239.31M1.62B80.07B---

Cash Flow

Currency: IDR2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-631.93M6.06B-36.95B-101.22B-62.68B46.21B
Investing Cash Flow0-4.83B-6.74B-33.28B-63.61B-9.67B
Financing Cash Flow871.25M156.58M122.13B119.25B64.90B-9.88B
Capital Expenditure04.83B6.74B33.28B63.61B366.76M
Free Cash Flow-1.23B----
FCF to OCF-20.29%----

Earnings

Report DateMar 31, 2023Jun 30, 2023
EPS Estimate--
EPS Actual4.542.33
Surprise--
Timing--

Key Statistics & Ratios

Market Cap4.44T
Enterprise Value4.40T
Trailing P/E23.96
Forward P/E0.00
Price / Sales22.99
Price / Book0.00
EPS38.61
Book Value39.14
Revenue (TTM)193.12B
Gross Profit (TTM)115.49B
EBITDA111.10B
Profit Margin2.61%
Operating Margin-1.61%
Return on Equity2.73%
Return on Assets4.43%
Shares Outstanding4.80B
Shares Float1.32B
Beta1.57
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 24, 20252:1